The findings come on the heels of the US Food and Drug Administration approving the Harmony system (Medtronic) in March as the first nonsurgical heart valve to treat pulmonary valve regurgitation in ...
The FDA approved a new version of Edwards Lifesciences’ Sapien 3 transcatheter heart valve—coupling it with a self-expanding, stent-like device that helps reshape a malfunctioning pulmonary valve.
$2M Grant to Speed PolyVascular’s Pediatric Catheter-Delivered Pulmonary Valve Replacement to Market
Powered by SBIR grant funding, PolyVascular advances options for children in need of pulmonary valve replacement with its polymeric stent-mounted valve small enough for the tiniest patients. The ...
The US Food and Drug Administration (FDA) has cleared Edwards Lifesciences’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement, the manufacturer ...
EINDHOVEN, the Netherlands & ZURICH--(BUSINESS WIRE)--Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, today announced that it has started the ...
Medtronic delivered new data from two clinical trials evaluating the long-term safety and shorter-term performance of its transcatheter pulmonary valve replacement therapies for children with ...
Jasmine Harvey, 21, was born with the complex congenital heart condition tetralogy of Fallot and underwent open-heart surgery at St. Joseph’s Children’s Hospital when she was just 4-months-old. This ...
Kenyatta National Hospital has successfully performed Kenya’s first balloon pulmonary valvuloplasty on a premature newborn, ...
The FDA gave the greenlight to transcatheter pulmonic valve replacement with the Sapien 3 system plus an adaptive pre-stent landing zone, dubbed Alterra, for patients with congenital heart disease.
Researchers from the BioTis laboratory (Inserm/University of Bordeaux, Bordeaux, France) have developed a pulmonary valve using human collagen. Such a device could revolutionize the treatment of ...
Chicago, September 24, 2014 – Researchers have found a way to take a pediatric patient's skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results